2016 Marks 1 Million Gamma Knife Patients Treated

2016 Marks 1 Million Gamma Knife Patients Treated

In 1987, Gamma Knife stereotactic radiosurgery was introduced in the United States, marking a powerful new weapon in the fight against brain tumors. Nearly 30 years later, the groundbreaking treatment is reaching a significant milestone: By the end of the year, more than 1 million patients will have received Gamma Knife treatment since its inception. Annually, around 70,000 patients undergo Gamma Knife surgery for benign and malignant tumors, according to the device’s manufacturer.

“The volume of Gamma Knife patients treated speaks to the treatment’s advanced approach and Gamma Knife surgery’s success rate,” says Neurosurgeon Anthony D’Ambrosio, M.D., Co-Director of the Gamma Knife Center. “It’s a proven radiosurgical treatment that has years of evidence behind it.”

Valley’s team, too, has years of experience in delivering the innovative treatment. Since opening in 2011, the Gamma Knife Center has treated hundreds of patients, and its team has more than 20 years of combined experience. Recently, The Gamma Knife Center was selected to be one of only 30 elite, high-volume centers to join the Stereotactic Radiosurgery Registry.

By comparison, Gamma Knife’s leading competitor, CyberKnife, has treated 100,000 patients as of 2010, according to the latest information available on the manufacturer’s website. Learn more about the differences between Gamma Knife and CyberKnife.

How do I know if Gamma Knife treatment is right for me?

Complete the contact form below or call The Gamma Knife Center at The Valley Hospital at 201-634-5677 to set up a consultation and receive more information.

Get Your Questions Answered, By a Real Person.

Our Patient Liaison is here to help you understand your next step. After discussing your specific case, she can help you navigate your medical records, answer insurance questions, and connect you with one of our nurses, at no charge to you.

Patient liaisons explain Gamma Knife surgery cost, outcomes, etc.